Systemic Complications of Diabetes Mellitus Robert F. Nash D.O. Robert F. Nash D.O. 2006 2006
Dec 29, 2015
Diabetes “The term diabetes was coined by Aretaeus (81–133 CE) of
Cappadocia. The Greek word diabaínein literally means "passing through," or "siphon," a reference to one of diabetes' major symptoms—excessive urine production. The word became "diabetes" from the English adoption of the medieval Latin diabetes. In 1675 Thomas Willis added mellitus from the Latin word for honey (mel in the sense of "honey sweet") when he noted that the blood and urine of a diabetic has a sweet taste. This had been noticed long before in ancient times by the Greeks, Chinese, Egyptians, and Indians. In 1776 it was confirmed the sweet taste was because of an excess of a kind of sugar in the urine and blood of people with diabetes.”
Prevalence (2005)
Total population in USTotal population in US 20.8 million people (7%)20.8 million people (7%)
Diagnosed 14.6 millionDiagnosed 14.6 millionUndiagnosed 6.2 millionUndiagnosed 6.2 million
Age 60 and overAge 60 and over 10.3 million people10.3 million people 20.9%20.9%
Cost
Health Care CostHealth Care Cost Other costsOther costs
DisabilityDisability Work LossWork Loss Premature Premature
MortalityMortality Total CostTotal Cost
$92 BILLION$92 BILLION $40 BILLION$40 BILLION
$132 BILLION$132 BILLION
Mrs. Adams
Age 51Age 51 New PatientNew Patient Not under any Not under any
Physicians carePhysicians care
CC: Check-upCC: Check-up HPI: “ I am just not feeling HPI: “ I am just not feeling
well.” Tired, polyuria, well.” Tired, polyuria, polyphagia, polydypsea, some polyphagia, polydypsea, some weight loss, abdominal pain, weight loss, abdominal pain, diarrhea, leg pain, sores on feet, diarrhea, leg pain, sores on feet, dyspepsia, occasional episodes dyspepsia, occasional episodes of chest pain, difficulty seeing, of chest pain, difficulty seeing, ankle edema, and rash. ankle edema, and rash.
Type I Diabetes Mellitus
““Juvenille Diabetes”- MisnomerJuvenille Diabetes”- Misnomer Autoimmune processAutoimmune process Requires Insulin secondary to beta-cell Requires Insulin secondary to beta-cell
destructiondestruction Look for other autoimmune conditionsLook for other autoimmune conditions
Gestational Diabetes Mellitus
Unknown etiology- May be secondary to Unknown etiology- May be secondary to maternal hormonesmaternal hormones
Resolves with delivery/termination of Resolves with delivery/termination of pregnancypregnancy
Watch for Hypoglycemia of neonateWatch for Hypoglycemia of neonate Insulin for managementInsulin for management
Type II Diabetes Mellitus
Decreased insulin sensitivityDecreased insulin sensitivity Initial hyperinsulinemiaInitial hyperinsulinemia ““Burn-out of Beta cells”Burn-out of Beta cells” Oral and /or Insulin therapyOral and /or Insulin therapy
Other causes
Chronic pancreatitisChronic pancreatitis Endocrine disordersEndocrine disorders Medication induced Diabetes MellitusMedication induced Diabetes Mellitus Genetic SyndromesGenetic Syndromes Genetic DefectsGenetic Defects
Diabetic Emergencies
Diabetic KetoacidosisDiabetic Ketoacidosis Non-ketotic hyperglycemic-hyperosmolar Non-ketotic hyperglycemic-hyperosmolar
ComaComa
Systemic Complications of Diabetes Mellitus CardiovascularCardiovascular NeurologicNeurologic GastrointestinalGastrointestinal EyesEyes Oral CavityOral Cavity SkinSkin GenitourinaryGenitourinary RenalRenal
Pathogenesis
Increased glucose levelsIncreased glucose levels Insulin sensitive cellsInsulin sensitive cells
MuscleMuscle Cells not requiring insulinCells not requiring insulin
Cardiovascular
Heart disease and stroke incidenceHeart disease and stroke incidence 2-4 times higher than rest of population2-4 times higher than rest of population
Accelerated atherosclerosisAccelerated atherosclerosis Increased cholesterol levelsIncreased cholesterol levels Hypertension 73%Hypertension 73%
Neurologic
60%-70% with mild to severe neurologic 60%-70% with mild to severe neurologic diseasedisease
Carpal Tunnel SyndromeCarpal Tunnel Syndrome
Diabetic NeuropathyDiabetic Neuropathy About 60-70% of people with
diabetes have mild to severe forms of nervous system damage, including:
Impaired sensation or pain in the feet or hands
Slowed digestion of food in the stomach
Carpal tunnel syndrome
Other nerve problems
More than 60% of nontraumaticlower-limb amputations in the United States occur among people with diabetes.
Amputations
Major contributing cause of lower extremity Major contributing cause of lower extremity amputationsamputations
82,000 yearly (2000-2001)82,000 yearly (2000-2001) Loss of sensationLoss of sensation
Gastrointestinal
Polyphagia and PolydyspeaPolyphagia and Polydyspea Autonomic NeuropathyAutonomic Neuropathy
Decreased peristalsisDecreased peristalsisGastroparesisGastroparesisEsophagealEsophageal
Diarrhea and ConstipationDiarrhea and Constipation Decreased exocrine pancreatic secretionsDecreased exocrine pancreatic secretions
Lumbar and Thoracic PolyradiculopathyLumbar and Thoracic Polyradiculopathy
Eyes
Blindness ages 20-74Blindness ages 20-74 12,000 to 24,000 new cases of blindness 12,000 to 24,000 new cases of blindness
yearlyyearly Retinopathy-late first decade to early Retinopathy-late first decade to early
secondsecond Macular EdemaMacular Edema CataractsCataracts Blurry visionBlurry vision
Oral Cavity
Periodontal Disease- 1/3 of all diabeticsPeriodontal Disease- 1/3 of all diabetics ThrushThrush
Genitourinary
PolyuriaPolyuria Female ReproductionFemale Reproduction
Poorly controlled diabeticsPoorly controlled diabeticsPrior to conception to end of first 1/3Prior to conception to end of first 1/3
• 5-10% birth defects5-10% birth defects
• 15-20% abort15-20% abort2/3 to birth causes high birth weight2/3 to birth causes high birth weight
Genitourinary
Female GenitourinaryFemale Genitourinary Vaginal CandidisisVaginal Candidisis DyspareuniaDyspareunia UTI’sUTI’s Bladder dysfunctionBladder dysfunction
Male Genitialia
Erectile dysfunctionErectile dysfunction Decreased libidoDecreased libido UTI’sUTI’s
Renal
44 % of all End Stage Renal Disease44 % of all End Stage Renal Disease Glomerular lesionsGlomerular lesions ArteriolosclerosisArteriolosclerosis PyelonephritisPyelonephritis
NephropathyFive Stages of Kidney DiseaseFive Stages of Kidney DiseaseStage 1: Hyperfiltration, or an increase in glomerular filtration rate (GFR) occurs. Kidneys increase in size.
Stage 2: Glomeruli begin to show damage and microalbuminurea occurs.
Stage 3: Albumin excretion rate (AER) exceeds 200 micrograms/minute, and blood levels of creatinine and urea-nitrogen rise. Blood pressure may rise during this stage.
Five Stages of Kidney Disease (con’t.)
Five Stages of Kidney Disease (con’t.)
Stage 4: GFR decreases to less than 75 ml/min, large amounts of protein pass into the urine, and high blood pressure almost always occurs. Levels of creatinine and urea-nitrogen in the blood rise further.
Stage 5: Kidney failure, or end stage renal disease (ESRD). GFR is less than 10 ml/min. The average length of time to progress from Stage 1 to Stage 4 kidney disease is 17 years for a person with type 1 diabetes. The average length of time to progress to Stage 5, kidney failure, is 23 years.
Treatment
Diabetes Type IIDiabetes Type II Weight loss and dietary changeWeight loss and dietary change Adjust medications to keep Fasting Adjust medications to keep Fasting
Glucose between 90 and 130Glucose between 90 and 130 HGBHGBa1c a1c Below 7.0
Pain managementPain management
Treatment of Diabetic Nephropathy
Hypertension Control - Goal: lower blood pressure to <130/80 Hypertension Control - Goal: lower blood pressure to <130/80 mmHg mmHg Antihypertensive agentsAntihypertensive agents
Angiotensin-converting enzyme (ACE) inhibitorsAngiotensin-converting enzyme (ACE) inhibitors
• captopril, enalapril, lisinopril, benazepril, captopril, enalapril, lisinopril, benazepril, fosinopril, ramipril, quinapril, perindopril, fosinopril, ramipril, quinapril, perindopril, trandolapril, moexipriltrandolapril, moexipril
Angiotensin receptor blocker (ARB) therapy Angiotensin receptor blocker (ARB) therapy • candesartan cilexetil, irbesartan, losartan candesartan cilexetil, irbesartan, losartan
potassium, telmisartan, valsartan, esprosartan potassium, telmisartan, valsartan, esprosartan
Beta-blockersBeta-blockers
Prevention of Diabetic Retinopathy Associated Vision Loss
Intensive glycemic controlIntensive glycemic control Tight blood pressure control Tight blood pressure control
(<130/80 mmHg)(<130/80 mmHg) Comprehensive eye examinations Comprehensive eye examinations
Treatment GIGI
Metoclopramide or erythromycinMetoclopramide or erythromycin Loperamide or stool softnersLoperamide or stool softners
PolyneuropathyPolyneuropathy AntidepressantAntidepressant AnticonvulsantsAnticonvulsants Regular foot examsRegular foot exams
Erectile DysfunctionErectile Dysfunction DyspareuniaDyspareunia
LubricantsLubricants Estrogen CreamEstrogen Cream
References
American Diabetes Association:American Diabetes Association: Preventive Foot Care in DiabetesPreventive Foot Care in Diabetes(Position Statement).(Position Statement). Diabetes Care Diabetes Care 27 (Suppl.1): S63-S64, 2004 27 (Suppl.1): S63-S64, 2004
Feldman, EL: Classification of diabetic neuropathy. In Feldman, EL: Classification of diabetic neuropathy. In UpToDate.UpToDate.Wellesley, MA, UpToDate, 2003Wellesley, MA, UpToDate, 2003
National Diabetes Information Clearinghouse. National Diabetes Information Clearinghouse. Diabetic Neuropathies:Diabetic Neuropathies:The Nerve Damage of Diabetes. The Nerve Damage of Diabetes. Bethesda, MD: National Institute ofBethesda, MD: National Institute ofDiabetes and Digestive and Kidney Diseases, National Institutes ofDiabetes and Digestive and Kidney Diseases, National Institutes ofHealth (NIH), DHHS; 2002Health (NIH), DHHS; 2002
National Diabetes Information Clearinghouse. National Diabetes Information Clearinghouse. Prevent DiabetesPrevent DiabetesProblems: Keep Your Feet and Skin Healthy. Problems: Keep Your Feet and Skin Healthy. Bethesda, MD: NationalBethesda, MD: NationalInstitute of Diabetes and Digestive and Kidney Diseases, NationalInstitute of Diabetes and Digestive and Kidney Diseases, NationalInstitutes of Health (NIH), DHHS; 2003Institutes of Health (NIH), DHHS; 2003
References, cont.
Feldman, EL: Pathogenesis and prevention of diabeticFeldman, EL: Pathogenesis and prevention of diabeticpolyneuropathy. In polyneuropathy. In UpToDate.UpToDate. Wellesley, MA, UpToDate, 2003. Wellesley, MA, UpToDate, 2003.
Feldman, EL, McCulloch, DK: Treatment of diabetic neuropathy. InFeldman, EL, McCulloch, DK: Treatment of diabetic neuropathy. InUpToDate.UpToDate. Wellesley, MA, UpToDate, 2003. Wellesley, MA, UpToDate, 2003.
Stevens, MJ: Diabetic autonomic neuropathy. In Stevens, MJ: Diabetic autonomic neuropathy. In UpToDate.UpToDate.Wellesley, MA, UpToDate, 2003.Wellesley, MA, UpToDate, 2003.
Feldman, EL: Clinical manifestations and diagnosis of diabeticFeldman, EL: Clinical manifestations and diagnosis of diabeticpolyneuropathy. In polyneuropathy. In UpToDate.UpToDate. Wellesley, MA, UpToDate, 2003. Wellesley, MA, UpToDate, 2003.
ReferencesAmerican Diabetes Association:American Diabetes Association: Nephropathy in DiabetesNephropathy in Diabetes (Position(PositionStatement).Statement). Diabetes Care Diabetes Care 27 (Suppl.1): S79-S83, 2004 27 (Suppl.1): S79-S83, 2004
National Kidney and Urologic Diseases Information Clearinghouse.National Kidney and Urologic Diseases Information Clearinghouse.Kidney Disease of Diabetes. Kidney Disease of Diabetes. Bethesda, MD: National Institute ofBethesda, MD: National Institute ofDiabetes and Digestive and Kidney Diseases, National Institutes ofDiabetes and Digestive and Kidney Diseases, National Institutes ofHealth (NIH), DHHS; 2003. Health (NIH), DHHS; 2003.
United States Renal Data System. United States Renal Data System. USRDS 2003 Annual DataUSRDS 2003 Annual DataReportReport. Bethesda, MD: National Institute of Diabetes and Digestive. Bethesda, MD: National Institute of Diabetes and Digestiveand Kidney Diseases, National Institutes of Health (NIH), DHHS;and Kidney Diseases, National Institutes of Health (NIH), DHHS;2003. 2003.
DeFronzo RA: Diabetic nephropathy: etiologic and therapeuticDeFronzo RA: Diabetic nephropathy: etiologic and therapeuticconsiderations. considerations. Diabetes ReviewsDiabetes Reviews 3:510-547, 1995 3:510-547, 1995
National Kidney and Urologic Diseases Information Clearinghouse.National Kidney and Urologic Diseases Information Clearinghouse.Kidney Failure: Choosing a Treatment That’s Right For You.Kidney Failure: Choosing a Treatment That’s Right For You.Bethesda, MD: National Institute of Diabetes and Digestive andBethesda, MD: National Institute of Diabetes and Digestive andKidney Diseases, National Institutes of Health (NIH), DHHS; 2003. Kidney Diseases, National Institutes of Health (NIH), DHHS; 2003.
References
American Diabetes Association:American Diabetes Association: Retinopathy in DiabetesRetinopathy in Diabetes (Position(PositionStatement).Statement). Diabetes Care Diabetes Care 27 (Suppl.1): S84-S87, 200427 (Suppl.1): S84-S87, 2004
Diabetic Retinopathy: What you should know. Diabetic Retinopathy: What you should know. Bethesda, MD: NationalBethesda, MD: NationalEye Institute, National Institutes of Health (NIH), DHHS; 2004.Eye Institute, National Institutes of Health (NIH), DHHS; 2004.
Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD,Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD,Ferris FL 3rd, Klein R: Diabetic Retinopathy. Ferris FL 3rd, Klein R: Diabetic Retinopathy. Diabetes CareDiabetes Care 21 (1): 21 (1):143-156,1998.143-156,1998.